Nano-therapeutics: A revolution in infection control in post antibiotic era

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 13, Issue 7, 2017, Pages 2281-2301

  Zaidi, Sahar ^a   Misba, Lama ^a   Khan, Asad U ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Antibiotic resistance; Bacterial infection; Drug delivery; Multidrug resistant strains; Nanoparticle

Indexed keywords

ANTIBIOTICS; DIAGNOSIS; DISEASE CONTROL; DRUG DELIVERY; NANOPARTICLES; TARGETED DRUG DELIVERY;

ANTI-BACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTIONS; INFECTION CONTROL; INFECTIOUS DISEASE; MULTIDRUG RESISTANTS; NANOPARTICLE (NPS); PARADIGM SHIFTS;

CONTROLLED DRUG DELIVERY;

ALUMINUM NANOPARTICLE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BEHENIC ACID; CARBON NANOTUBE; COPPER NANOPARTICLE; GENTAMICIN; GOLD NANOPARTICLE; LIPOSOME; MESOPOROUS SILICA NANOPARTICLE; METAL ION; MULTI WALLED NANOTUBE; NANOBUBBLE; NANOCARRIER; NANOCOMPOSITE; NANOPARTICLE; PALLADIUM NANOPARTICLE; PLATINUM NANOPARTICLE; POLYPEPTIDE ANTIBIOTIC AGENT; QUANTUM DOT; SILICA NANOPARTICLE; SILVER NANOPARTICLE; SILVER QUANTUM DOT; SINGLE WALLED NANOTUBE; SOLID LIPID NANOPARTICLE; TITANIUM NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; VACCINE; ZINC DOPED COPPER OXIDE NANOCOMPOSITE; ZINC NANOPARTICLEE; DRUG CARRIER;

ANTIBACTERIAL ACTIVITY; BACTERIAL INFECTION; BACTERIAL STRAIN; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; INFECTION CONTROL; MICELLE; OXIDATIVE STRESS; REVIEW; THERANOSTIC NANOMEDICINE; VACCINATION; ANIMAL; ANTIBIOTIC RESISTANCE; BACTERIUM; CHEMISTRY; DRUG EFFECT; HUMAN; MULTIDRUG RESISTANCE; NANOMEDICINE; NANOTECHNOLOGY; PROCEDURES;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; NANOMEDICINE; NANOPARTICLES; NANOTECHNOLOGY;

EID: 85026624359     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2017.06.015     Document Type: Review

References (200)

1. Courtney, C.M., Goodman, S.M., McDaniel, J.A., Madinger, N.E., Chatterjee, A., Nagpal, P., Photoexcited quantum dots for killing multidrug-resistant bacteria. Nat Mater 15:5 (2016), 529–534.
2. Alekshun, M.N., Levy, S.B., Molecular mechanisms of antibacterial multidrug resistance. Cell 128:6 (2007), 1037–1050.
3. Briones, E., Colino, C.I., Lanao, J.M., Delivery systems to increase the selectivity of antibiotics in phagocytic cells. J Control Release 125:3 (2008), 210–227.
4. Lembo, D., Cavalli, R., Nanoparticulate delivery systems for antiviral drugs. Antivir Chem Chemother 21:2 (2010), 53–70.
5. Mhango, E.K., Kalhapure, R.S., Jadhav, M., Sonawane, S.J., Mocktar, C., Vepuri, S., et al. Preparation and optimization of Meropenem-loaded solid lipid nanoparticles: in vitro evaluation and molecular modeling. AAPS PharmSciTech, 2016, 1–15.
6. Plank, C., Nanomedicine: silence the target. Nat Nanotechnol 4:9 (2009), 544–545.
7. Qayyum, S., Khan, A.U., Nanoparticles vs. biofilms: a battle against another paradigm of antibiotic resistance. Med Chem Commun 7:8 (2016), 1479–1498.
8. Italia, J.L., Sharp, A., Carter, K.C., Warn, P., Kumar, M.N., Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome(R) or Fungizone. PLoS One, 6(10), 2011, e25744.
9. Rastogi, L., Kora, A.J., Arunachalam, J., Highly stable, protein capped gold nanoparticles as effective drug delivery vehicles for amino-glycosidic antibiotics. Mater Sci Eng C 32:6 (2012), 1571–1577.
10. Allahverdiyev, A.M., Kon, K.V., Abamor, E.S., Bagirova, M., Rafailovich, M., Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Expert Rev Anti Infect Ther 9:11 (2011), 1035–1052.
11. Aditya, N.P., Vathsala, P.G., Vieira, V., Murthy, R.S., Souto, E.B., Advances in nanomedicines for malaria treatment. Adv Colloid Interface Sci 201 (2013), 1–17.
12. Gurunathan, S., Han, J.W., Dayem, A.A., Eppakayala, V., Kim, J.H., Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas Aeruginosa. Int J Nanomedicine, 7(5901), 2012, e14.
13. Nagy, A., Harrison, A., Sabbani, S., Munson, R.S. Jr., Dutta, P.K., Waldman, W.J., Silver nanoparticles embedded in zeolite membranes release of silver ions and mechanism of antibacterial action. Int J Nanomedicine 6 (2011), 1833–1852.
14. Leung, Y.H., Ng, A.M., Xu, X., Shen, Z., Gethings, L.A., Wong, M.T., et al. Mechanisms of antibacterial activity of MgO: non-ROS mediated toxicity of MgO nanoparticles towards Escherichia Coli. Small 10:6 (2014), 1171–1183.
15. Sirelkhatim, A., Mahmud, S., Seeni, A., Kaus, N.H., Ann, L.C., Bakhori, S.K., et al. Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism. Nano-Micro Lett 7:3 (2015), 219–242.
16. Davis, M.E., Chen, Z., Shin, D.M., Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 7:9 (2008), 771–782.
17. Chetoni, P., Burgalassi, S., Monti, D., Tampucci, S., Tullio, V., Cuffini, A.M., et al. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery pharmacokinetic studies on rabbits. Eur J Pharm Biopharm 109 (2016), 214–223.
18. Bozzuto, G., Molinari, A., Liposomes as nanomedical devices. Int J Nanomedicine, 10, 2015, 975.
19. Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S.W., Zarghami, N., Hanifehpour, Y., et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett, 8(1), 2013, 102.
20. Kumari, A., Yadav, S.K., Yadav, S.C., Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 75:1 (2010), 1–18.
21. Muhamad, I.I., Selvakumaran, S., Lazim, N.A.M., Designing polymeric nanoparticles for targeted drug delivery system. Nanomedicine, 287, 2014, 287.
22. Cabral, H., Kataoka, K., Progress of drug-loaded polymeric micelles into clinical studies. J Control Release 190 (2014), 465–476.
23. Sosnik, A., Raskin, M.M., Polymeric micelles in mucosal drug delivery: challenges towards clinical translation. Biotechnol Adv 33:6 (2015), 1380–1392.
24. Amjad, M.W., Kesharwani, P., Amin, M.C.I.M., Iyer, A.K., Recent advances in the design, development, and targeting mechanisms of polymeric micelles for delivery of siRNA in cancer therapy. Prog Polym Sci 64 (2017), 154–181.
25. Yadav, N.E.H.A., Khatak, S.U.N.I.L., Sara, U.V.S., Solid lipid nanoparticles-a review. Int J Appl Pharm 5:2 (2013), 8–18.
26. Dinali, R., Ebrahiminezhad, A., Manley-Harris, M., Ghasemi, Y., Berenjian, A., Iron oxide nanoparticles in modern microbiology and biotechnology. Crit Rev Microbiol, 2017, 1–15.
27. Zanganeh, S., Hutter, G., Spitler, R., Lenkov, O., Mahmoudi, M., Shaw, A., et al. Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. Nat Nanotechnol 11:11 (2016), 986–994.
28. Laurent, S., Mahmoudi, M., Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer. Int J Mol Epidemiol Genet 2:4 (2011), 367–390.
29. Drbohlavova, J., Adam, V., Kizek, R., Hubalek, J., Quantum dots—characterization, preparation and usage in biological systems. Int J Mol Sci 10:2 (2009), 656–673.
30. Panchapakesan, B., Book-Newell, B., Sethu, P., Rao, M., Irudayaraj, J., Gold nanoprobes for theranostics. Nanomedicine 6:10 (2011), 1787–1811.
31. Huang, X., El-Sayed, M.A., Gold nanoparticles: optical properties and implementations in cancer diagnosis and photothermal therapy. J Adv Res 1:1 (2010), 13–28.
32. Schrand, A.M., Rahman, M.F., Hussain, S.M., Schlager, J.J., Smith, D.A., Syed, A.F., Metal-based nanoparticles and their toxicity assessment. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2:5 (2010), 544–568.
33. Gupta, U., Jain, N.K., Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting. Adv Drug Deliv Rev 62:4 (2010), 478–490.
34. Ding, L., Liu, Z., Okweesi Aggrey, M., Li, C., Chen, J., Tong, L., Nanotoxicity: the toxicity research progress of metal and metal-containing nanoparticles. Mini-Rev Med Chem 15:7 (2015), 529–542.
35. Zhang, X.F., Liu, Z.G., Shen, W., Gurunathan, S., Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches. Int J Mol Sci, 17(9), 2016, 1534.
36. Wang, Y., Zhao, Q., Han, N., Bai, L., Li, J., Liu, J., et al. Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine 11:2 (2015), 313–327.
37. Bharti, C., Nagaich, U., Pal, A.K., Gulati, N., Mesoporous silica nanoparticles in target drug delivery system: a review. Int J Pharm Investig, 5(3), 2015, 124.
38. Arvizo, R.R., Bhattacharyya, S., Kudgus, R.A., Giri, K., Bhattacharya, R., Mukherjee, P., Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev 41:7 (2012), 2943–2970.
39. Barroso, M.M., Quantum dots in cell biology. J Histochem Cytochem 59:3 (2011), 237–251.
40. Resch-Genger, U., Grabolle, M., Cavaliere-Jaricot, S., Nitschke, R., Nann, T., Quantum dots versus organic dyes as fluorescent labels. Nat Methods 5:9 (2008), 763–775.
41. Gao, C., Guo, Z., Liu, J.H., Huang, X.J., The new age of carbon nanotubes: an updated review of functionalized carbon nanotubes in electrochemical sensors. Nanoscale 4:6 (2012), 1948–1963.
42. Eatemadi, A., Daraee, H., Karimkhanloo, H., Kouhi, M., Zarghami, N., Akbarzadeh, A., et al. Carbon nanotubes: properties, synthesis, purification, and medical applications. Nanoscale Res Lett, 9(1), 2014, 393.
43. Frens, G., Controlled nucleation for the regulation of particle size in monodisperse gold suspensions. Nature 241:105 (1973), 20–22.
44. Ebina, K., Shi, K., Hirao, M., Hashimoto, J., Kawato, Y., Kaneshiro, S., et al. Oxygen and air nanobubble water solution promote the growth of plants, fishes, and mice. PLoS One, 8(6), 2013, e65339.
45. Ge, L., Li, Q., Wang, M., Ouyang, J., Li, X., Xing, M.M., Nanosilver particles in medical applications: synthesis, performance, and toxicity. Int J Nanomedicine, 9, 2014, 2399.
46. Li, K., Liu, B., Polymer-encapsulated organic nanoparticles for fluorescence and photoacoustic imaging. Chem Soc Rev 43:18 (2014), 6570–6597.
47. Puri, A., Loomis, K., Smith, B., Lee, J.H., Yavlovich, A., Heldman, E., et al. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst, 26(6), 2009.
48. Patel, P.A., Patravale, V.B., AmbiOnp: solid lipid nanoparticles of amphotericin B for oral administration. J Biomed Nanotechnol 7:5 (2011), 632–639.
49. Ghaffar, K.A., Giddam, A.K., Zaman, M., Skwarczynski, M., Toth, I., Liposomes as nanovaccine delivery systems. Curr Top Med Chem 14:9 (2014), 1194–1208.
50. Jain, R.A., The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices. Biomaterials 21:23 (2000), 2475–2490.
51. Mishra, D., Jain, N., Rajoriya, V., Jain, A.K., Glycyrrhizin conjugated chitosan nanoparticlesfor hepatocyte-targeted delivery of lamivudine. J Pharm Pharmacol 66:8 (2014), 1082–1093.
52. Goncalves, I.C., Henriques, P.C., Seabra, C.L., Martins, M.C., The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection. Expert Rev Anti Infect Ther 12:8 (2014), 981–992.
53. Bawa, P., Pillay, V., Choonara, Y.E., Du Toit, L.C., Stimuli-responsive polymers and their applications in drug delivery. Biomed Mater, 4(2), 2009, 022001.
54. Kaur, M., Garg, T., Rath, G., Goyal, A.K., Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst 31:1 (2014), 49–88.
55. Zazo, H., Colino, I.C., Lanao, M.J., Current applications of nanoparticles in infectious diseases. J Control Release 224 (2016), 86–102.
56. Mahajan, S.D., Aalinkeel, R., Law, W.C., Reynolds, J.L., Nair, B.B., Sykes, D.E., et al. Anti-HIV-1 nanotherapeutics: promises and challenges for the future. Int J Nanomedicine 7 (2012), 5301–5314.
57. Turkevich, J., Colloidal gold part I. Gold Bull 18:3 (1985), 86–91.
58. Ghosh P, Han G, De M, Kim CK, Rotello VM. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 60(11):1307–1315.
59. Mody, V.V., Siwale, R., Singh, A., Mody, H.R., Introduction to metallic nanoparticles. J Pharm Bioallied Sci, 2(4), 2010, 282.
60. Zhao, Y., Jiang, X., Multiple strategies to activate gold nanoparticles as antibiotics. Nanoscale 5:18 (2013), 8340–8350.
61. Sengupta, J., Ghosh, S., Datta, P., Gomes, A., Gomes, A., Physiologically important metal nanoparticles and their toxicity. J Nanosci Nanotechnol 14:1 (2014), 990–1006.
62. Gupta, A.K., Naregalkar, R.R., Vaidya, V.D., Gupta, M., Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2 (2007), 23–39.
63. Corchero, J.L., Villaverde, A., Biomedical applications of distally controlled magnetic nanoparticles. Trends Biotechnol 27:8 (2009), 468–476.
64. Gijs, M.A., Lacharme, F., Lehmann, U., Microfluidic applications of magnetic particles for biological analysis and catalysis. Chem Rev 110:3 (2009), 1518–1563.
65. Valencia, P.M., Farokhzad, O.C., Karnik, R., Langer, R., Microfluidic technologies for accelerating the clinical translation of nanoparticles. Nat Nanotechnol 7:10 (2012), 623–629.
66. Chung, H.J., Castro, C.M., Im, H., Lee, H., Weissleder, R., A magneto-DNA nanoparticle system for rapid detection and phenotyping of bacteria. Nat Nanotechnol 8:5 (2013), 369–375.
67. Mocan, L., Matea, C., Tabaran, F.A., Mosteanu, O., Pop, T., Puia, C., et al. Selective in vitro photothermal nano-therapy of MRSA infections mediated by IgG conjugated gold nanoparticles. Sci Rep, 2016, 6.
68. Khan, S., Alam, F., Azam, A., Khan, A.U., Gold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit Candida Albicans biofilm. Int J Nanomedicine 7 (2012), 3245–3257.
69. Lim, S., Koo, O.K., You, Y.S., Lee, Y.E., Kim, M.S., Chang, P.S., et al. Enhancing nanoparticle-based visible detection by controlling the extent of aggregation. Sci Rep, 2, 2012, 456.
70. Rai, M.K., Deshmukh, S.D., Ingle, A.P., Gade, A.K., Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria. J Appl Microbiol 112:5 (2012), 841–852.
71. Qayyum, S., Khan, A.U., Biofabrication of broad range antibacterial and antibiofilm silver nanoparticles. IET Nanobiotechnol 10:5 (2016), 349–357.
72. Kulshrestha, S., Qayyum, S., Khan, A.U., Antibiofilm efficacy of green synthesized graphene oxide-silver nanocomposite using Lagerstroemia Speciosa floral extract: a comparative study on inhibition of gram-positive and gram-negative biofilms. Microb Pathog 103 (2017), 167–177.
73. Misba, L., Kulshrestha, S., Khan, A.U., Antibiofilm action of a toluidine blue O-silver nanoparticle conjugate on Streptococcus Mutans: a mechanism of type I photodynamic therapy. Biofouling 32:3 (2016), 313–328.
74. Saeb, A., Alshammari, A.S., Al-Brahim, H., Al-Rubeaan, K.A., Production of silver nanoparticles with strong and stable antimicrobial activity against highly pathogenic and multidrug resistant bacteria. Sci World J, 2014, 2014.
75. Duncan, R., Gaspar, R., Nanomedicine (s) under the microscope. Mol Pharm 8:6 (2011), 2101–2141.
76. Leevy, W.M., Lambert, T.N., Johnson, J.R., Morris, J., Smith, B.D., Quantum dot probes for bacteria distinguish escherichia coli mutants and permit in vivo imaging. Chem Commun 20 (2008), 2331–2333.
77. Pati, R., Sahu, R., Panda, J., Sonawane, A., Encapsulation of zinc-rifampicin complex into transferrin-conjugated silver quantum-dots improves its antimycobacterial activity and stability and facilitates drug delivery into macrophages. Sci Rep, 2016, 6.
78. Kulshrestha, S., Khan, S., Meena, R., Singh, B.R., Khan, A.U., A graphene/zinc oxide nanocomposite film protects dental implant surfaces against cariogenic Streptococcus mutans. Biofouling 30:10 (2014), 1281–1294.
79. Sani, Usman M., Synthesis, characterization, and antimicrobial properties of copper nanoparticles. Int J Nanomedicine 8 (2013), 4467–4479.
80. Kulshrestha, S., Khan, S., Hasan, S., Khan, M.E., Misba, L., Khan, A.U., Calcium fluoride nanoparticles induced suppression of Streptococcus Mutans biofilm: an in vitro and in vivo approach. Appl Microbiol Biotechnol 100:4 (2016), 1901–1914.
81. Maleki Dizaj, S., Mennati, A., Jafari, S., Khezri, K., Adibkia, K., Antimicrobial activity of carbon-based nanoparticles. Adv Pharm Bull 5:1 (2015), 19–23.
82. Pruthi, J., Mehra, N.K., Jain, N.K., Macrophages targeting of amphotericin B through mannosylated multiwalled carbon nanotubes. J Drug Target 20:7 (2012), 593–604.
83. Saikia, N., Rajkhowa, S., Deka, R.C., Density functional and molecular docking studies towards investigating the role of single-wall carbon nanotubes as nanocarrier for loading and delivery of pyrazinamide antitubercular drug onto pncA protein. J Comput Aided Mol Des 27:3 (2013), 257–276.
84. Cavalli, R., Bisazza, A., Lembo, D., Micro-and nanobubbles: a versatile non-viral platform for gene delivery. Int J Pharm 456:2 (2013), 437–445.
85. Wang, L., Hu, C., Shao, L., The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int J Nanomedicine, 12, 2017, 1227.
86. Wang, Y., Ding, X., Chen, Y., Guo, M., Zhang, Y., Guo, X., et al. Antibiotic-loaded, silver core-embedded mesoporous silica nanovehicles as a synergistic antibacterial agent for the treatment of drug-resistant infections. Biomaterials 101 (2016), 207–216.
87. Malka, E., Perelshtein, I., Lipovsky, A., Shalom, Y., Naparstek, L., Perkas, N., et al. Eradication of multi-drug resistant bacteria by a novel Zn-doped CuO nanocomposite. Small 9:23 (2013), 4069–4076.
88. Wu, B., Zhuang, W.Q., Sahu, M., Biswas, P., Tang, Y.J., Cu-doped TiO 2 nanoparticles enhance survival of Shewanella oneidensis MR-1 under ultraviolet light (UV) exposure. Sci Total Environ 409:21 (2011), 4635–4639.
89. Yu, J., Zhang, W., Li, Y., Wang, G., Yang, L., Jin, J., et al. Synthesis, characterization, antimicrobial activity and mechanism of a novel hydroxyapatite whisker/nano zinc oxide biomaterial. Biomed Mater, 10(1), 2014, 015001.
90. Losasso, C., Belluco, S., Cibin, V., Zavagnin, P., Mičetić, I., Gallocchio, F., et al. Antibacterial activity of silver nanoparticles: sensitivity of different salmonella serovars. Front Microbiol, 5, 2014, 227.
91. Lesniak, A., Salvati, A., Santos-Martinez, M.J., Radomski, M.W., Dawson, K.A., Åberg, C., Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J Am Chem Soc 135 (2013), 1438–1444.
92. Sarwar, A., Katas, H., Samsudin, S.N., Zin, N.M., Regioselective sequential modification of chitosan via Azide-alkyne click reaction: synthesis, characterization, and antimicrobial activity of chitosan derivatives and nanoparticles. PLoS One, 10(4), 2015, e0123084.
93. Joost, U., Juganson, K., Visnapuu, M., Mortimer, M., Kahru, A., Nõmmiste, E., et al. Photocatalytic antibacterial activity of nano-TiO 2 (anatase)-based thin films: effects on Escherichia Coli cells and fatty acids. J Photochem Photobiol B Biol 142 (2015), 178–185.
94. Zhukova, L.V., Evidence for compression of Escherichia Coli K12 cells under the effect of TiO2 nanoparticles. ACS Appl Mater Interfaces 7:49 (2015), 27197–27205.
95. Su, Y., Zheng, X., Chen, Y., Li, M., Liu, K., Alteration of intracellular protein expressions as a key mechanism of the deterioration of bacterial denitrification caused by copper oxide nanoparticles. Sci Rep, 5, 2015, 15824.
96. Petros, R.A., DeSimone, J.M., Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9:8 (2010), 615–627.
97. Moghimi, S.M., Hunter, A.C., Murray, J.C., Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:2 (2001), 283–318.
98. Dobrovolskaia, M.A., McNeil, S.E., Immunological properties of engineered nanomaterials. Nat Nanotechnol 2:8 (2007), 469–478.
99. Serda, R.E., Ferrati, S., Godin, B., Tasciotti, E., Liu, X., Ferrari, M., Mitotic trafficking of silicon microparticles. Nanoscale 1:2 (2009), 250–259.
100. Torchilin, V.P., Trubetskoy, V.S., Which polymers can make nanoparticulate drug carriers long-circulating?. Adv Drug Deliv Rev 16:2–3 (1995), 141–155.
101. Adams, M.L., Lavasanifar, A., Kwon, G.S., Amphiphilic block copolymers for drug delivery. J Pharm Sci 92:7 (2003), 1343–1355.
102. Champion, J.A., Mitragotri, S., Role of target geometry in phagocytosis. Proc Natl Acad Sci U S A 103:13 (2006), 4930–4934.
103. Geng, Y.A.N., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol 2:4 (2007), 249–255.
104. Patil, S., Sandberg, A., Heckert, E., Self, W., Seal, S., Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials 28:31 (2007), 4600–4607.
105. Tantra, R., Schulze, P., Quincey, P., Effect of nanoparticle concentration on zeta-potential measurement results and reproducibility. Particuology 8:3 (2010), 279–285.
106. Abdulkarim, M., Agulló, N., Cattoz, B., Griffiths, P., Bernkop-Schnürch, A., Borros, S.G., et al. Nanoparticle diffusion within intestinal mucus: three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles. Eur J Pharm Biopharm 97 (2015), 230–238.
107. Chellat, F., Merhi, Y., Moreau, A., Yahia, L.H., Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials 26:35 (2005), 7260–7275.
108. Bertrand, N., Leroux, J.C., The journey of a drug-carrier in the body: an anatomo-physiological perspective. J Control Release 161:2 (2012), 152–163.
109. Qi, G., Li, L., Yu, F., Wang, H., Vancomycin-modified mesoporous silica nanoparticles for selective recognition and killing of pathogenic gram-positive bacteria over macrophage-like cells. ACS Appl Mater Interfaces 5:21 (2013), 10874–10881.
110. Gao, W., Thamphiwatana, S., Angsantikul, P., Zhang, L., Nanoparticle approaches against bacterial infections. Wiley Interdiscip Rev Nanomed Nanobiotechnol 6:6 (2014), 532–547.
111. DiStasi, M.R., Ley, K., Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability. Trends Immunol 30:11 (2009), 547–556.
112. Azzopardi, E.A., Ferguson, E.L., Thomas, D.W., The enhanced permeability retention effect: a new paradigm for drug targeting in infection. J Antimicrob Chemother 68:2 (2013), 257–274.
113. Dillen, K., Bridts, C., Van der Veken, P., Cos, P., Vandervoort, J., Augustyns, K., et al. Adhesion of PLGA or Eudragit®/PLGA nanoparticles to staphylococcus and pseudomonas. Int J Pharm 349:1 (2008), 234–240.
114. Sambhy, V., Peterson, B.R., Sen, A., Antibacterial and hemolytic activities of pyridinium polymers as a function of the spatial relationship between the positive charge and the pendant alkyl tail. Angew Chem Int Ed 47:7 (2008), 1250–1254.
115. Gunaseelan, S., Gunaseelan, K., Deshmukh, M., Zhang, X., Sinko, P.J., Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs. Adv Drug Deliv Rev 62:4 (2010), 518–531.
116. Byrne, J.D., Betancourt, T., Brannon-Peppas, L., Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 60:15 (2008), 1615–1626.
117. Farkhani, S.M., Valizadeh, A., Karami, H., Mohammadi, S., Sohrabi, N., Badrzadeh, F., Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules. Peptides 57 (2014), 78–94.
118. Bahnsen, J.S., Franzyk, H., Sandberg-Schaal, A., Nielsen, H.M., Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure. Biochim Biophys Acta 1828:2 (2013), 223–232.
119. Kell, A.J., Stewart, G., Ryan, S., Peytavi, R., Boissinot, M., Huletsky, A., et al. Vancomycin-modified nanoparticles for efficient targeting and preconcentration of gram-positive and gram-negative bacteria. ACS Nano 2:9 (2008), 1777–1788.
120. Chen, J., Zhang, C., Liu, Q., Shao, X., Feng, C., Shen, Y., et al. Solanum Tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations. J Drug Target 20:2 (2012), 174–184.
121. Umamaheshwari, R.B., Jain, N.K., Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of helicobacter pylori. J Drug Target 11:7 (2003), 415–424.
122. Huang, P.J., Tay, L.L., Tanha, J., Ryan, S., Chau, L.K., Single-domain antibody-conjugated nanoaggregate-embedded beads for targeted detection of pathogenic bacteria. Chemistry 15:37 (2009), 9330–9334.
123. Tay, L.L., Huang, P.J., Tanha, J., Ryan, S., Wu, X., Hulse, J., et al. Silica encapsulated SERS nanoprobe conjugated to the bacteriophage tailspike protein for targeted detection of salmonella. Chem Commun 48:7 (2012), 1024–1026.
124. Kawakami, S., Hashida, M., Glycosylation-mediated targeting of carriers. J Control Release 190 (2014), 542–555.
125. Kreuter, J., Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?. Adv Drug Deliv Rev 71 (2014), 2–14.
126. Kuo, Y.C., Ko, H.F., Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles. Biomaterials 34:20 (2013), 4818–4830.
127. Lobenberg, R., Araujo, L., Von Briesen, H., Rodgers, E., Kreuter, J., Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.V. Injection to rats. J Control Release 50:1 (1998), 21–30.
128. Xu, N., Gu, J., Zhu, Y., Wen, H., Ren, Q., Chen, J., Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice. Int J Nanomedicine 6 (2011), 905–913.
129. Baxt, L.A., Garza-Mayers, A.C., Goldberg, M.B., Bacterial subversion of host innate immune pathways. Science 340:6133 (2013), 697–701.
130. Laverman, P., Dams, E.T.M., Storm, G., Hafmans, T.G., Croes, H.J., Oyen, W.J., et al. Microscopic localization of PEG-liposomes in a rat model of focal infection. J Control Release 75:3 (2001), 347–355.
131. Kaim, A.H., Wischer, T., O'Reilly, T., Jundt, G., Fröhlich, J., von Schulthess, G.K., et al. MR imaging with Ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats 1. Radiology 225:3 (2002), 808–814.
132. Mehta, R.T., McQueen, T.J., Keyhani, A., López-Berestein, G., Phagocyte transport as mechanism for enhanced therapeutic activity of liposomal amphotericin B. Chemotherapy 40:4 (1994), 256–264.
133. Vyas, S.P., Kannan, M.E., Jain, S., Mishra, V., Singh, P., Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int J Pharm 269:1 (2004), 37–49.
134. Xiong, M.H., Li, Y.J., Bao, Y., Yang, X.Z., Hu, B., Wang, J., Bacteria-responsive multifunctional nanogel for targeted antibiotic delivery. Adv Mater 24:46 (2012), 6175–6180.
135. Chen, F., Zhou, J., Luo, F., Mohammed, A.B., Zhang, X.L., Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent mycobacterium tuberculosis. Biochem Biophys Res Commun 357:3 (2007), 743–748.
136. Duan, N., Wu, S., Chen, X., Huang, Y., Xia, Y., Ma, X., et al. Selection and characterization of aptamers against salmonella typhimurium using whole-bacterium systemic evolution of ligands by exponential enrichment (SELEX). J Agric Food Chem 61:13 (2013), 3229–3234.
137. Gao, W., Chan, J., Farokhzad, O.C., pH-responsive nanoparticles for drug delivery. Mol Pharm, 7(6), 2010, 1913.
138. Fullriede, H., Abendroth, P., Ehlert, N., Doll, K., Schäske, J., Winkel, A., et al. pH-responsive release of chlorhexidine from modified nanoporous silica nanoparticles for dental applications. BioNanoMaterials 17:1–2 (2016), 59–72.
139. Zhang, L., Granick, S., How to stabilize phospholipid liposomes (using nanoparticles). Nano Lett 6:4 (2006), 694–698.
140. Zhang, L., Hong, L., Yu, Y., Bae, S.C., Granick, S., Nanoparticle-assisted surface immobilization of phospholipid liposomes. J Am Chem Soc 128:28 (2006), 9026–9027.
141. Simões, S., Moreira, J.N., Fonseca, C., Düzgüneş, N., de Lima, M.C.P., On the formulation of pH-sensitive liposomes with long circulation times. Adv Drug Deliv Rev 56:7 (2004), 947–965.
142. Pornpattananangkul, D., Olson, S., Aryal, S., Sartor, M., Huang, C.M., Vecchio, K., et al. Stimuli-responsive liposome fusion mediated by gold nanoparticles. ACS Nano, 4(4), 2010, 1935.
143. Gao, W., Vecchio, D., Li, J., Zhu, J., Zhang, Q., Fu, V., et al. Hydrogel containing nanoparticle-stabilized liposomes for topical antimicrobial delivery. ACS Nano 8:3 (2014), 2900–2907.
144. Radovic-Moreno, A.F., Lu, T.K., Puscasu, V.A., Yoon, C.J., Langer, R., Farokhzad, O.C., Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. ACS Nano, 6(5), 2012, 4279.
145. Xiong, M.H., Bao, Y., Yang, X.Z., Wang, Y.C., Sun, B., Wang, J., Lipase-sensitive polymeric triple-layered nanogel for “on-demand” drug delivery. J Am Chem Soc 134:9 (2012), 4355–4362.
146. Lin, Y.H., Chang, C.H., Wu, Y.S., Hsu, Y.M., Chiou, S.F., Chen, Y.J., Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-helicobacter pylori therapy. Biomaterials 30:19 (2009), 3332–3342.
147. Longmire, M., Choyke, P.L., Kobayashi, H., Clearance Properties of Nano-Sized Particles and Molecules as Imaging Agents: Considerations and Caveats. 2008, 703–717.
148. Choi, H.S., Liu, W., Misra, P., Tanaka, E., Zimmer, J.P., Ipe, B.I., et al. Renal clearance of quantum dots. Nat Biotechnol 25:10 (2007), 1165–1170.
149. Deen, W.M., Lazzara, M.J., Myers, B.D., Structural determinants of glomerular permeability. Am J Physiol 281:4 (2001), F579–F596.
150. Kuntz, E., Kuntz, H.D., Hepatology, Principles and Practice: History, Morphology, Biochemistry, Diagnostics, Clinic, Therapy. 2006, Springer Science & Business Media, 19–24.
151. Oh, N., Park, J.H., Surface chemistry of gold nanoparticles mediates their exocytosis in macrophages. ACS Nano 8:6 (2014), 6232–6241.
152. Hamblin, K.A., Armstrong, S.J., Barnes, K.B., Davies, C., Laws, T., Blanchard, J.D., et al. Inhaled liposomal ciprofloxacin protects against a lethal infection in a murine model of pneumonic plague. Front Microbiol, 2017, 8.
153. Castoldi, A., Herr, C., Niederstraßer, J., Labouta, H.I., Melero, A., Gordon, S., et al. Calcifediol-loaded liposomes for local treatment of pulmonary bacterial infections. Eur J Pharm Biopharm, 2016.
154. Liu, X., Li, Z., Wang, X., Chen, Y., Wu, F., Men, K., et al. Novel antimicrobial peptide–modified azithromycin-loaded liposomes against methicillin-resistant Staphylococcus Aureus. Int J Nanomedicine, 11, 2016, 6781.
155. Park, S.C., Kim, N.H., Yang, W., Nah, J.W., Jang, M.K., Lee, D., Polymeric micellar nanoplatforms for Fenton reaction as a new class of antibacterial agents. J Control Release 221 (2016), 37–47.
156. Liu, Y., Busscher, H.J., Zhao, B., Li, Y., Zhang, Z., van der Mei, H.C., et al. Surface-adaptive, antimicrobially loaded, micellar nanocarriers with enhanced penetration and killing efficiency in staphylococcal biofilms. ACS Nano 10:4 (2016), 4779–4789.
157. Xie, S., Yang, F., Tao, Y., Chen, D., Qu, W., Huang, L., et al. Enhanced intracellular delivery and antibacterial efficacy of enrofloxacin-loaded docosanoic acid solid lipid nanoparticles against intracellular salmonella. Sci Rep, 2017, 7.
158. Yousry, C., Fahmy, R.H., Essam, T., El-Laithy, H.M., Elkheshen, S.A., Nanoparticles as tool for enhanced ophthalmic delivery of vancomycin: a multidistrict-based microbiological study, solid lipid nanoparticles formulation and evaluation. Drug Dev Ind Pharm 42:11 (2016), 1752–1762.
159. Bazzaz, B.S.F., Khameneh, B., Zarei, H., Golmohammadzadeh, S., Antibacterial efficacy of rifampin loaded solid lipid nanoparticles against Staphylococcus Epidermidis biofilm. Microb Pathog 93 (2016), 137–144.
160. Geilich, B.M., Gelfat, I., Sridhar, S., van de Ven, A.L., Webster, T.J., Superparamagnetic iron oxide-encapsulating polymersome nanocarriers for biofilm eradication. Biomaterials 119 (2017), 78–85.
161. Niemirowicz, K., Piktel, E., Wilczewska, A.Z., Markiewicz, K.H., Durnaś, B., Wątek, M., et al. Core–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas Aeruginosa and Staphylococcus Aureus when combined with cathelicidin ll-37 or selected ceragenins. Int J Nanomedicine, 11, 2016, 5443.
162. Shi, S.F., Jia, J.F., Guo, X.K., Zhao, Y.P., Chen, D.S., Guo, Y.Y., et al. Reduced Staphylococcus Aureus biofilm formation in the presence of chitosan-coated iron oxide nanoparticles. Int J Nanomedicine, 11, 2016, 6499.
163. Casciaro, B., Moros, M., Rivera-Fernández, S., Bellelli, A., Jesús, M., Mangoni, M.L., Gold-nanoparticles coated with the antimicrobial peptide esculentin-1a (1-21) NH 2 as a reliable strategy for antipseudomonal drugs. Acta Biomater 47 (2017), 170–181.
164. Ahmed, A., Khan, A.K., Anwar, A., Ali, S.A., Shah, M.R., Biofilm inhibitory effect of chlorhexidine conjugated gold nanoparticles against Klebsiella Pneumoniae. Microb Pathog 98 (2016), 50–56.
165. Kalita, S., Kandimalla, R., Sharma, K.K., Kataki, A.C., Deka, M., Kotoky, J., Amoxicillin functionalized gold nanoparticles reverts MRSA resistance. Mater Sci Eng C 61 (2016), 720–727.
166. Mu, H., Liu, Q., Niu, H., Sun, Y., Duan, J., Gold nanoparticles make chitosan–streptomycin conjugates effective towards gram-negative bacterial biofilm. RSC Adv 6:11 (2016), 8714–8721.
167. Panáček, A., Smékalová, M., Večeřová, R., Bogdanová, K., Röderová, M., Kolář, M., et al. Silver nanoparticles strongly enhance and restore bactericidal activity of inactive antibiotics against multiresistant enterobacteriaceae. Colloids Surf B Biointerfaces 142 (2016), 392–399.
168. Wan, G., Ruan, L., Yin, Y., Yang, T., Ge, M., Cheng, X., Effects of silver nanoparticles in combination with antibiotics on the resistant bacteria Acinetobacter Baumannii. Int J Nanomedicine, 11, 2016, 3789.
169. Priebe, M., Widmer, J., Löwa, N.S., Abram, S.L., Mottas, I., Woischnig, A.K., et al. Antimicrobial silver-filled silica nanorattles with low immunotoxicity in dendritic cells. Nanomedicine 13:1 (2017), 11–22.
170. Wang, J., Wu, G., Liu, X., Sun, G., Li, D., Wei, H., A decomposable silica-based antibacterial coating for percutaneous titanium implant. Int J Nanomedicine, 12, 2017, 371.
171. Lee, B.Y., Li, Z., Clemens, D.L., Dillon, B.J., Hwang, A.A., Zink, J.I., et al. Redox-triggered release of moxifloxacin from mesoporous silica nanoparticles functionalized with disulfide snap-tops enhances efficacy against pneumonic tularemia in mice. Small 12:27 (2016), 3690–3702.
172. Kim, T., Braun, G.B., She, Z.G., Hussain, S., Ruoslahti, E., Sailor, M.J., Composite porous silicon–silver nanoparticles as Theranostic antibacterial agents. ACS Appl Mater Interfaces 8:44 (2016), 30449–30457.
173. Woźniak-Budych, M.J., Przysiecka, Ł., Langer, K., Peplińska, B., Jarek, M., Wiesner, M., et al. Green synthesis of rifampicin-loaded copper nanoparticles with enhanced antimicrobial activity. J Mater Sci Mater Med, 28(3), 2017, 42.
174. Deokar, A.R., Shalom, Y., Perelshtein, I., Perkas, N., Gedanken, A., Banin, E., A topical antibacterial ointment made of Zn-doped copper oxide nanocomposite. J Nanopart Res, 18(8), 2016, 218.
175. Chen, S., Quan, Y., Yu, Y.L., Wang, J.H., Graphene quantum dot/silver nanoparticle hybrids with oxidase activities for antibacterial application. ACS Biomater Sci Eng 3:3 (2017), 313–321.
176. Song, D., Qu, X., Liu, Y., Li, L., Yin, D., Li, J., et al. A rapid detection method of Brucella with quantum dots and magnetic beads conjugated with different polyclonal antibodies. Nanoscale Res Lett, 12(1), 2017, 179.
177. Li, Y.J., Harroun, S.G., Su, Y.C., Huang, C.F., Unnikrishnan, B., Lin, H.J., et al. Synthesis of self-assembled spermidine-carbon quantum dots effective against multidrug-resistant bacteria. Adv Healthc Mater 5:19 (2016), 2545–2554.
178. Mocan, L., Ilie, I., Tabaran, F.A., Iancu, C., Mosteanu, O., Pop, T., et al. Selective laser ablation of methicillin-resistant staphylococcus aureus with IgG functionalized multi-walled carbon nanotubes. J Biomed Nanotechnol 12:4 (2016), 781–788.
179. Chaudhari, A.A., deb Nath, S., Kate, K., Dennis, V., Singh, S.R., Owen, D.R., et al. A novel covalent approach to bio-conjugate silver coated single walled carbon nanotubes with antimicrobial peptide. J Nanobiotechnol, 14(1), 2016, 58.
180. Hansen, S., Lehr, C.M., Nanoparticles for transcutaneous vaccination. J Microbial Biotechnol 5:2 (2012), 156–167.
181. Misstear, K., McNeela, E.A., Murphy, A.G., Geoghegan, J.A., O'keeffe, K.M., Fox, J., et al. Targeted nasal vaccination provides antibody-independent protection against Staphylococcus Aureus. J Infect Dis 209:9 (2014), 1479–1484.
182. Fauci, A.S., Morens, D.M., The perpetual challenge of infectious diseases. N Engl J Med 366:5 (2012), 454–461.
183. Swartz, M.A., Hirosue, S., Hubbell, J.A., Engineering approaches to immunotherapy. Sci Transl Med, 4(148), 2012 [148rv9-148rv9].
184. Irvine, D.J., Swartz, M.A., Szeto, G.L., Engineering synthetic vaccines using cues from natural immunity. Nat Mater 12:11 (2013), 978–990.
185. Ha, N.Y., Shin, H.M., Sharma, P., Cho, H.A., Min, C.K., Kim, H.I., et al. Generation of protective immunity against Orientia tsutsugamushi infection by immunization with a zinc oxide nanoparticle combined with ScaA antigen. J Nanobiotechnol, 14(1), 2016, 76.
186. Tan, M.L., Choong, P.F., Dass, C.R., Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Peptides 31:1 (2010), 184–193.
187. Gu, Z., Biswas, A., Zhao, M., Tang, Y., Tailoring nanocarriers for intracellular protein delivery. Chem Soc Rev 40:7 (2011), 3638–3655.
188. Villa, C.H., Dao, T., Ahearn, I., Fehrenbacher, N., Casey, E., Rey, D.A., et al. Single-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigens. ACS Nano 5:7 (2011), 5300–5311.
189. Sahdev, P., Ochyl, L.J., Moon, J.J., Biomaterials for nanoparticle vaccine delivery systems. Pharm Res 31:10 (2014), 2563–2582.
190. Kaba, S.A., McCoy, M.E., Doll, T.A., Brando, C., Guo, Q., Dasgupta, D., et al. Protective antibody and CD8+ T-cell responses to the plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine. PLoS One, 7(10), 2012, e48304.
191. Dierendonck, M., De Koker, S., Cuvelier, C., Grooten, J., Vervaet, C., Remon, J.P., et al. Facile two-step synthesis of porous antigen-loaded degradable polyelectrolyte microspheres. Angew Chem Int Ed 49:46 (2010), 8620–8624.
192. Perry, J.L., Herlihy, K.P., Napier, M.E., DeSimone, J.M., PRINT: a novel platform toward shape and size specific nanoparticle theranostics. Acc Chem Res, 44(10), 2011, 990.
193. Mueller, S.N., Tian, S., DeSimone, J.M., Rapid and persistent delivery of antigen by lymph node targeting PRINT nanoparticle vaccine carrier to promote humoral immunity. Mol Pharm, 12(5), 2015, 1356.
194. De Rose, R., Zelikin, A.N., Johnston, A.P., Sexton, A., Chong, S.F., Cortez, C., et al. Binding, internalization, and antigen presentation of vaccine-loaded Nanoengineered capsules in blood. Adv Mater 20:24 (2008), 4698–4703.
195. Hu, C.M.J., Zhang, L., Aryal, S., Cheung, C., Fang, R.H., Zhang, L., Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci 108:27 (2011), 10980–10985.
196. Hu, C.M.J., Fang, R.H., Copp, J., Luk, B.T., Zhang, L., A biomimetic nanosponge that absorbs pore-forming toxins. Nat Nanotechnol 8:5 (2013), 336–340.
197. Hu, C.M.J., Fang, R.H., Luk, B.T., Zhang, L., Nanoparticle-detained toxins for safe and effective vaccination. Nat Nanotechnol 8:12 (2013), 933–938.
198. Peek, L.J., Middaugh, C.R., Berkland, C., Nanotechnology in vaccine delivery. Adv Drug Deliv Rev 60:8 (2008), 915–928.
199. Little, S.R., Reorienting our view of particle-based adjuvants for subunit vaccines. Proc Natl Acad Sci 109:4 (2012), 999–1000.
200. Zhu, Q., Egelston, C., Gagnon, S., Sui, Y., Belyakov, I.M., Klinman, D.M., et al. Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice. J Clin Invest 120:2 (2010), 607–616.